Neuromeka Rights Offering Ex-Date Set, Limited Dilution Risk
Neuromeka has announced a rights offering with an ex-rights date of June 19, 2026. The reference price is 47,550 KRW, approximately 2.2% below the current market price.
The exact size and use of proceeds are not disclosed, making it difficult to assess the precise dilution impact, but a standard rights offering is expected to have limited shareholder dilution.
[AI Summary]The rights offering ex-date notice confirms a planned capital raise, likely having a neutral short-term impact on stock price. Future announcements on terms and use of funds could introduce volatility.